06.05.2015 Views

crisil report - Diamines And Chemicals Limited

crisil report - Diamines And Chemicals Limited

crisil report - Diamines And Chemicals Limited

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Diamines</strong> and <strong>Chemicals</strong> Ltd<br />

Annexure 3: Financials<br />

Income statement<br />

Balance Sheet<br />

(Rs mn) FY09 FY10 FY11 FY12E FY13E (Rs mn) FY09 FY10 FY11 FY12E FY13E<br />

Operating income 303 456 828 909 1,099 Liabilities<br />

EBITDA 75 89 247 241 271 Equity share capital 65 65 65 97 97<br />

EBITDA margin 24.8% 19.5% 29.9% 26.5% 24.7% Reserves 67 145 245 233 334<br />

Depreciation 14 16 19 21 23 Minorities - - - - -<br />

EBIT 61 73 228 220 249 Net worth 132 210 311 330 431<br />

Interest 45 14 29 32 33 Convertible debt - - - - -<br />

Operating PBT 16 59 199 188 216 Other debt 175 187 272 282 282<br />

Other income 1 1 3 4 5 Total debt 175 187 272 282 282<br />

Exceptional inc/(exp) 4 85 2 - - Deferred tax liability (net) 32 38 33 28 23<br />

PBT 21 145 204 192 221 Total liabilities 339 435 616 641 736<br />

Tax provision 7 51 57 66 77 Assets<br />

Minority interest - - - - - Net fixed assets 232 300 312 382 374<br />

PAT (Reported) 14 94 147 127 144 Capital WIP 35 4 21 21 21<br />

Less: Exceptionals 4 85 2 - - Total fixed assets 267 304 333 402 395<br />

Adjusted PAT 9 9 146 127 144 Investments 1 1 1 1 1<br />

Current assets<br />

Ratios Inventory 102 133 138 174 271<br />

FY09 FY10 FY11 FY12E FY13E Sundry debtors 83 93 171 188 227<br />

Growth Loans and advances 31 102 108 118 143<br />

Operating income (%) 58.1 50.8 81.4 9.7 21.0 Cash & bank balance 29 35 90 24 74<br />

EBITDA (%) 42.2 18.6 177.3 (2.4) 12.5 Marketable securities - - - - -<br />

Adj PAT (%) (46.8) (5.0) 1,567.3 (12.9) 13.7 Total current assets 245 363 507 504 715<br />

Adj EPS (%) (46.8) (5.0) 1,567.3 (12.9) 13.7 Total current liabilities 174 233 225 266 374<br />

Net current assets 71 130 282 237 341<br />

Profitability Intangibles/Misc. expenditure - - - - -<br />

EBITDA margin (%) 24.8 19.5 29.9 26.5 24.7 Total assets 339 435 616 641 736<br />

Adj PAT Margin (%) 3.0 1.9 17.6 13.9 13.1<br />

RoE (%) 7.1 5.1 55.9 39.6 37.9 Cash flow<br />

RoCE (%) 20.6 20.7 46.6 36.9 37.5 (Rs mn) FY09 FY10 FY11 FY12E FY13E<br />

RoIC (%) 20.1 7.5 41.7 30.1 29.6 Pre-tax profit 17 60 202 192 221<br />

Total tax paid (9) (45) (62) (71) (82)<br />

Valuations Depreciation 14 16 19 21 23<br />

Price-earnings (x) 76.0 80.0 4.8 5.5 4.8 Working capital changes 30 (53) (98) (21) (53)<br />

Price-book (x) 5.3 3.3 2.2 2.1 1.6 Net cash from operations 52 (21) 61 121 108<br />

EV/EBITDA (x) 11.2 9.5 3.6 4.0 3.3 Cash from investments<br />

EV/Sales (x) 3.0 2.0 1.1 1.1 0.8 C apital expenditure (43) (54) (48) (90) (15)<br />

Dividend payout ratio (%) 47.8 13.9 26.6 24.9 24.9 Investments and others - - - - -<br />

Dividend yield (%) 0.9 1.9 5.6 4.5 5.1 Net cash from investments (43) (54) (48) (90) (15)<br />

Cash from financing<br />

B/S ratios Equity raised/(repaid) - - - - -<br />

Inventory days 170 138 90 99 124 Debt raised/(repaid) 16 12 86 10 -<br />

C reditors days 249 123 57 61 81 Dividend (incl. tax) (8) (15) (46) (38) (43)<br />

Debtor days 95 72 70 70 70 Others (incl extraordinaries) 4 85 0 (69) (0)<br />

Working capital days 68 55 63 82 80 Net cash from financing 13 81 41 (97) (43)<br />

Gross asset turnover (x) 0.7 0.9 1.5 1.5 1.6 Change in cash position 21 6 54 (66) 50<br />

Net asset turnover (x) 1.3 1.7 2.7 2.6 2.9 Closing cash 29 35 90 24 74<br />

Sales/operating assets (x) 1.2 1.6 2.6 2.5 2.8<br />

Current ratio (x) 1.4 1.6 2.3 1.9 1.9<br />

Debt-equity (x) 1.3 0.9 0.9 0.9 0.7 Quarterly financials<br />

Net debt/equity (x) 1.1 0.7 0.6 0.8 0.5 (Rs mn) Q1FY11 Q2FY11 Q3FY11 Q4FY11 Q1FY12<br />

Interest coverage 1.3 5.2 7.8 6.9 7.6 Net Sales 158 215 219 238 241<br />

C hange (q-o-q) 36% 2% 9% 1%<br />

EBITDA 46 93 55 54 71<br />

Per share C hange (q-o-q) 104% -41% -2% 33%<br />

FY09 FY10 FY11 FY12E FY13E EBITDA margin 29% 43% 25% 22% 30%<br />

Adj EPS (Rs) 0.9 0.9 15.0 13.0 14.8 PAT 23 58 27 38 42<br />

CEPS 2.4 2.6 16.9 15.2 17.1 Adj PAT 23 58 27 38 42<br />

Book value 13.6 21.6 32.0 33.9 44.3 C hange (q-o-q) 150% -54% 41% 10%<br />

Dividend (Rs) 0.7 1.3 4.0 3.2 3.7 Adj PAT margin 15% 27% 12% 16% 17%<br />

Actual o/s shares (mn) 9.7 9.7 9.7 9.7 9.7 Adj EPS 2.4 6.0 2.8 3.9 4.3<br />

Source: CRISIL Research<br />

© CRISIL <strong>Limited</strong>. All Rights Reserved. CRISIL RESEARCH | 28

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!